Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation
April 15, 2024 04:00 ET
|
Regeneron Ventures
GREENWICH, Conn., April 15, 2024 (GLOBE NEWSWIRE) -- Regeneron Ventures announces its formation as a venture capital fund focused on promising biopharmaceutical, health care and health technology...
SuRo Capital Corp. Announces Expiration and Final Results of Tender Offer
April 03, 2024 09:00 ET
|
SuRo Capital Corp.
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq: SSSS) today announced its final results from its modified “Dutch Auction” tender offer (the...
Spotlighting Excellence: Keiretsu Forum Curates Premiere Investment Opportunities for the 2024 Angel Capital Association Innovation Funders Showcase
April 02, 2024 06:08 ET
|
Keiretsu Forum Mid-Atlantic
Keiretsu Forum, a leader in angel investing, proudly announces its sponsorship of select pioneering companies for the ACA Summit in May 2024.
Australia’s private capital industry grew by 33 per cent in 18 months, reaching A$139 billion
April 01, 2024 17:00 ET
|
Preqin Ltd
The growth of Australia's private capital industry, looking at private equity, venture capital, and private credit. Includes assets under management data
New AI research helps VCs vet ideas 10x faster
March 27, 2024 08:00 ET
|
Vela Partners
Vela Partners and the University of Oxford publish new research about how venture capitalists can use artificial intelligence to vet ideas 10x faster.
LLM Fine-Tuning Startup OpenPipe Raises $6.7 Million
March 26, 2024 08:00 ET
|
OPENPIPE, INC.
SEATTLE, March 26, 2024 (GLOBE NEWSWIRE) -- OpenPipe, a tool that lets developers create their own application-specific Large Language Models (LLMs), today announced the closing of a $6.7 million...
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
March 25, 2024 07:48 ET
|
MetasTx LLC
Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.
SuRo Capital Corp. Tender Offer Expiring on April 1, 2024 at 5:00 P.M., Eastern Time
March 22, 2024 09:00 ET
|
SuRo Capital Corp.
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today reminded its stockholders its modified “Dutch Auction”...
Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors
March 21, 2024 07:00 ET
|
Cancer Focus Fund; Eisbach Bio GmbH
Cancer Focus Fund is investing $4.5M for clinical trial of Eisbach's novel approach using synthetic lethality to kill PARP inhibitor resistant tumors
Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines
March 21, 2024 03:00 ET
|
Angelini Ventures
Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing roundFinancing will enable Nouscom to continue advancing the clinical development of...